Clinical Trials / Browse by Phase / Phase 4
Browse by Phase

Phase 4 Clinical Trials

Phase 4 trials (post-market surveillance) occur after a drug has been approved. They monitor long-term effectiveness and safety in general patient populations.

Total Trials
342
Recruiting Now
342
Top Conditions in Phase 4
Obesity (6) Coronary Artery Disease (6) Heart Failure (5) Breast Cancer (4) Smoking Cessation (4) Bacteremia (3) Schizophrenia (3) Diabetes (3) Type 2 Diabetes (3) Cardiovascular Diseases (3)

Frequently Asked Questions — Phase 4 Trials

What is the purpose of a Phase 4 post-market clinical trial?
Phase 4 trials occur after a drug has received regulatory approval. They monitor long-term effectiveness and safety in real-world patient populations, detect rare adverse events too infrequent to appear in earlier trials, study effectiveness in subgroups (elderly, pediatric, renally impaired), and may explore new indications for the approved drug. Some Phase 4 studies are mandated by the FDA as a condition of approval.
Who sponsors Phase 4 trials?
Phase 4 trials are primarily sponsored by pharmaceutical and biotech companies that hold the drug's marketing authorization. Some are mandated by the FDA or EMA—particularly when approval was based on surrogate endpoints and confirmatory long-term data is required. Independent academic institutions and registry-based programs also conduct Phase 4 studies.
Are Phase 4 trials safer than Phase 1–3 trials?
Phase 4 trials involve drugs that have already demonstrated an acceptable safety profile in earlier phases and received regulatory approval. As a result, the risk profile for participants is generally better characterized than in early-phase trials. However, these studies are still clinical research designed partly to detect long-term or rare adverse events not observed in pre-approval trials.

Active Phase 4 Studies

NCT07863635 Phase 4
Recruiting
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-co...
Condition
SARS-CoV-2
Enrollment
600 pts
Location
United States
Sponsor
ModernaTX, Inc.
View Trial →
NCT07096908 Phase 4
Recruiting
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Condition
Type1diabetes
Enrollment
60 pts
Location
Kuwait
Sponsor
Dasman Diabetes Institute
View Trial →
NCT07217678 Phase 4
Recruiting
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive...
Condition
Glaucoma
Enrollment
20 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07007143 Phase 4
Recruiting
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Rep...
Condition
Mitral Regurgitation
Enrollment
1,032 pts
Location
China
Sponsor
Chinese Academy of Medical Sci
View Trial →
NCT06935708 Phase 4
Recruiting
Intrathecal Morphine Versus Epidural Analgesia for Open Colon Surgery
Condition
Colorectal Carcinoma
Enrollment
98 pts
Location
Croatia
Sponsor
Meri Mirceta
View Trial →
NCT06261840 Phase 4
Recruiting
Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative An...
Condition
Trichomonas Vaginitis
Enrollment
1,200 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT06594068 Phase 4
Recruiting
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in A...
Condition
Systemic Lupus Erythematosus
Enrollment
16 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT07895420 Phase 4
Recruiting
Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Op...
Condition
No Condition
Enrollment
80 pts
Location
United States
Sponsor
Retina Research Institute, LLC
View Trial →
NCT06848946 Phase 4
Recruiting
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alon...
Condition
Glaucoma, Open-angle
Enrollment
132 pts
Location
United States
Sponsor
Glaukos Corporation
View Trial →
NCT06930573 Phase 4
Recruiting
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellula...
Condition
HCC
Enrollment
30 pts
Location
China
Sponsor
The First Affiliated Hospital
View Trial →
NCT07684742 Phase 4
Recruiting
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndro...
Condition
Acute Coronary Syndromes
Enrollment
2,200 pts
Location
South Korea
Sponsor
Gyeongsang National University
View Trial →
NCT06587880 Phase 4
Recruiting
The Effect of Different Types of Mouthwash on Extraction Sockets' Healing
Condition
Extraction Socket Healing
Enrollment
100 pts
Location
Jordan
Sponsor
University of Jordan
View Trial →
NCT07384403 Phase 4
Recruiting
Application of Topical Oxygen Therapy Around Customized Healing Collar
Condition
Soft Tissue
Enrollment
6 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT07084402 Phase 4
Recruiting
Short-term Bactericidal Effect of Contezolid in MAC-PD
Condition
Mycobacterium Avium Complex Pulmonary Disease
Enrollment
188 pts
Location
China
Sponsor
Bin Cao
View Trial →
NCT06284473 Phase 4
Recruiting
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
Condition
Pain, Procedural
Enrollment
108 pts
Location
United States
Sponsor
Loyola University
View Trial →
NCT07083063 Phase 4
Recruiting
Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreat...
Condition
Pancreatitis
Enrollment
440 pts
Location
Taiwan
Sponsor
National Cheng-Kung University
View Trial →
NCT06639828 Phase 4
Recruiting
Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-E...
Condition
Focal Liver Lesions
Enrollment
50 pts
Location
Germany, Italy, United Kingdom
Sponsor
GE Healthcare
View Trial →
NCT07224711 Phase 4
Recruiting
The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-C...
Condition
Pain
Enrollment
2,290 pts
Location
United States
Sponsor
Vanderbilt University Medical
View Trial →
NCT06734598 Phase 4
Recruiting
Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Pati...
Condition
Trismus
Enrollment
120 pts
Location
Taiwan
Sponsor
National Taiwan University Hos
View Trial →
NCT05137119 Phase 4
Recruiting
Staphylococcus Aureus Network Adaptive Platform Trial
Condition
Staphylococcus Aureus Bacteremia
Enrollment
8,000 pts
Location
United States, Australia, Canada
Sponsor
University of Melbourne
View Trial →
NCT07843264 Phase 4
Recruiting
PPI Dosing Per CYP2C19 Genotype
Condition
Gastroesophageal Reflux Disease With Esophagitis
Enrollment
200 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT07124299 Phase 4
Recruiting
Alpha-Blockers Prior to Ureteral Access Sheath Placement in Flexible Ureteroscop...
Condition
Nephrolithiasis
Enrollment
140 pts
Location
Brazil
Sponsor
Pedro de Figueiredo Buchalla
View Trial →
NCT07314684 Phase 4
Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
Condition
T2DM (Type 2 Diabetes Mellitus)
Enrollment
80 pts
Location
Italy
Sponsor
Federico II University
View Trial →
NCT07138560 Phase 4
Recruiting
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
Condition
Parkinson Disease
Enrollment
22 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT05786417 Phase 4
Recruiting
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and...
Condition
Angina
Enrollment
741 pts
Location
United States
Sponsor
Yale University
View Trial →
Page 4 of 14 — 342 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology